Sage Therapeutics: U.S. FDA Grants SAGE-718 Orphan Drug Designation for the Treatment of Huntington'...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_2884470851

Sage Therapeutics: U.S. FDA Grants SAGE-718 Orphan Drug Designation for the Treatment of Huntington's Disease

Full title

Sage Therapeutics: U.S. FDA Grants SAGE-718 Orphan Drug Designation for the Treatment of Huntington's Disease

Publisher

Jacksonville: Close-Up Media, Inc

Journal title

Wireless News, 2023

Language

English

Formats

Publisher

Jacksonville: Close-Up Media, Inc

Subjects and topics

Full title

Sage Therapeutics: U.S. FDA Grants SAGE-718 Orphan Drug Designation for the Treatment of Huntington's Disease

Record Identifier

TN_cdi_proquest_wirefeeds_2884470851

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_2884470851

Log in as a Library member

Celebrating and sharing stories of Indigenous Australia, and helping to locate and prioritise Indigenous voices in the Library's collections.

Learning programs and resources linked to the curriculum.

Showcasing people, places and ideas inspired by the collection and the library community.